Matthew S Mc Ilwain is Director of Nautilus Biotechnology, Inc.. Currently has a direct ownership of 459,075 shares of NAUT, which is worth approximately $807,972. The most recent transaction as insider was on Nov 15, 2021, when has been sold 100,000 shares (Common Stock) at a price of $5.3 per share, resulting in proceeds of $530,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 459K
0% 3M change
0% 12M change
Total Value Held $807,972

Matthew S McIlwain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2021
BUY
Open market or private purchase
$530,000 $5.3 p/Share
100,000 Added 17.89%
459,075 Common Stock
Aug 26 2021
BUY
Open market or private purchase
$90,276 $7.71 p/Share
11,709 Added 3.16%
359,075 Common Stock
Aug 25 2021
BUY
Open market or private purchase
$90,504 $7.74 p/Share
11,693 Added 3.26%
347,366 Common Stock
Aug 24 2021
BUY
Open market or private purchase
$104,202 $7.68 p/Share
13,568 Added 3.88%
335,673 Common Stock

Also insider at

SMAR
SMARTSHEET INC Technology
MSM

Matthew S Mc Ilwain

Director
Seattle, WA

Track Institutional and Insider Activities on NAUT

Follow Nautilus Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAUT shares.

Notify only if

Insider Trading

Get notified when an Nautilus Biotechnology, Inc. insider buys or sells NAUT shares.

Notify only if

News

Receive news related to Nautilus Biotechnology, Inc.

Track Activities on NAUT